Marknadsmeddelande 132/18 – Sista dag för handel med BTA i Nanologica AB

See market notice See market noticeSista dag för handel med bolagets betalda tecknade aktie, NICA BTA, är den 29 maj, 2018.

Information om betald tecknad aktie:
Kortnamn: NICA BTA
ISIN-kod: SE0011090810
Orderboks-ID: 4AGB
CFI: ESNUFR
FISN: NANOLOGICA/SH
Sista handelsdag: 29 maj, 2018

Stockholm den 24 maj, 2018

Spotlight
08-511 68 000
info@spotlightstockmarket.com

Se marknadsmeddelande

See market notice

About us

Nanologica is a Swedish life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company’s mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments. The company is headquartered in Södertälje and Nanologica’s share (NICA) is listed for trading on Nasdaq Stockholm Main Market.